We would like to inform you that the Board of Directors of the Company in its meeting held on Monday, 08th December, 2025 has inter-alia considered and approved the following: 1. Increase ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board, at its meeting on 08 December 2025, approved raising the authorised share capital from Rs. 13 crore to Rs. 40 crore (1.3 crore to 4 crore equity shares of Rs. 10 each) and adopting a new set of Articles of Association aligned with the Companies Act, 2013. It also approved issuing up to 2,83,33,333 convertible warrants on a preferential basis to 35 allottees at Rs. 12 per warrant (Rs. 10 face value plus Rs. 2 premium), aggregating to about Rs. 34 crore, with an 18-month conversion window. An Extra-Ordinary General Meeting has been scheduled for 08 January 2026, with 01 December 2026 as the e-voting cut-off date, to seek shareholder approval. A scrutinizer has been appointed for the e-voting and ballot process.
Existing shareholders face significant potential dilution: if all warrants are converted, equity expands roughly 4.5 times from about 80 lakh shares to about 3.63 crore shares. The low issue price of Rs. 12 (just Rs. 2 above face value) and the large size relative to current capital could weigh on the stock in the near term, though the Rs. 34 crore infusion may support business growth if deployed effectively.